Pharmafile Logo
Pharmafocus logo
Advanced Search

accounting

Showing 3 posts of 3 posts found.

samsung_bioepis

Samsung BioLogics delisted over accounting violations

November 14, 2018
Research and Development Business, Samsung, Samsung BioLogics, accounting, south korea

South Korean firm Samsung BioLogics has been delisted from the South Korean stock exchange. The decision has come after the …

News
samsung

Samsung Biologics shares fall by 20% after Korean investigation

November 13, 2018
Manufacturing and Production Shares, accounting, pharma, smasung biologics, stockmarket

Shares in Korean firm Samsung BioLogics plummeted this week, falling by as much as 20% on Monday, after the South …

News
valeant

Hard times continue for Valeant as ex-CEO investigated for fraud

November 1, 2016
Manufacturing and Production CEO, Valeant, Valeant Pharmaceuticals, accounting, fraud

Valeant Pharmaceuticals continues to have a tough time after Bloomsberg broke the story of how former CEO J. Michael Pearson …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026